Biocon takes a hit of over 5%
Shital Jibhe / 16 Aug 2017
Pharmaceutical major Biocon, which focuses on reducing the therapy costs of chronic diseases like autoimmune, diabetes, and cancer, has posted sluggish and negative movement in the market with its scrip falling by over 5% during Wednesday morning’s trade.
Pharmaceutical major Biocon, which focuses on reducing the therapy costs of chronic diseases like autoimmune, diabetes, and cancer, has posted sluggish and negative movement in the market with its scrip falling by over 5% during Wednesday morning’s trade.
The scrip was trading at Rs 337 per share, down by Rs 12.25 or 3.51% as at 0946 hours and hit an intraday low of Rs 330.10. It attracted a traded volume of 13,18,492 shares and value of Rs 4,436.20 lakhs on the NSE.
According to media reports, the company may have withdrawn a filing for Trastuzumab which received recent cGMP observations from the EMA.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.